BRIEF

on Aap Implantate AG (ETR:AAQ)

Aap Implantate AG Achieves Comprehensive MDR Certification

aap Implantate AG has successfully completed the Medical Device Regulation (MDR) certification for all its existing products. The company received the MDR certificate for Class IIb products, including plates and screws, finalizing their MDR certification process. This transition from the former Medical Device Directive (MDD) is crucial for the marketing of medical devices within the European Union post-transition periods.

Securing the MDR certification eliminates risks associated with failing to meet relevant deadlines and ensures long-term market access in the EU and CE-relevant markets. With this regulatory milestone achieved, aap plans to focus on the development of its product portfolio. The company intends to launch further developments of its LOQTEQ® product line in the latter half of 2026, anticipating a positive impact on sales from 2027 onwards.

R. E.

Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all Aap Implantate AG news